Harrow (FRA:3IP) Cyclically Adjusted FCF per Share: €-0.86 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3IP Harrow Inc FRA:3IP
76 GF Score
Price €35.60
GF Value €35.65
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Harrow Cyclically Adjusted FCF per Share?

Harrow FRA:3IP +7.88% 76 Cyclically Adjusted FCF per Share is €-0.86 as of Jun. 2026. GuruFocus rates FRA:3IP with a GF Score™ of 76/100 and a GF Value™ of €35.65 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Harrow's adjusted free cash flow per share for the three months ended in Jun. 2026 was €-0.239. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.86 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -12.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -12.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Harrow was 39.90% per year. The lowest was -20.70% per year. And the median was 19.50% per year.

As of today (2026-08-21), Harrow's current stock price is €35.60. Harrow's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was €-0.86. Harrow's Cyclically Adjusted Price-to-FCF of today is .


Harrow  (FRA:3IP) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Harrow Cyclically Adjusted FCF per Share Related Terms


Harrow Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Harrow's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harrow Cyclically Adjusted FCF per Share Chart

Harrow Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.60 -0.35 -0.75 -0.27 -0.15

Harrow Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.27 -0.16 -0.15 -0.21 -0.86

FRA:3IP vs XERS, PRGO, PAHC: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Harrow's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harrow Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harrow's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Harrow's Cyclically Adjusted Price-to-FCF falls into.


FRA:3IP
76GF Score
Harrow Inc FRA:3IP
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harrow Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Harrow's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.239/333.9520*333.9520
=-0.239

Current CPI (Jun. 2026) = 333.9520.

Harrow Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.314 241.428 -0.434
201612 -0.183 241.432 -0.253
201703 -0.207 243.801 -0.284
201706 -0.100 244.955 -0.136
201709 -0.105 246.819 -0.142
201712 -0.022 246.524 -0.030
201803 -0.048 249.554 -0.064
201806 0.034 251.989 0.045
201809 -0.013 252.439 -0.017
201812 -0.025 251.233 -0.033
201903 -0.060 254.202 -0.079
201906 0.014 256.143 0.018
201909 -0.005 256.759 -0.007
201912 0.020 256.974 0.026
202003 -0.029 258.115 -0.038
202006 -0.102 257.797 -0.132
202009 0.075 260.280 0.096
202012 -0.021 260.474 -0.027
202103 0.091 264.877 0.115
202106 0.133 271.696 0.163
202109 -0.076 274.310 -0.093
202112 -0.922 278.802 -1.104
202203 0.019 287.504 0.022
202206 0.159 296.311 0.179
202209 -0.055 296.808 -0.062
202212 -0.329 296.797 -0.370
202303 -4.292 301.836 -4.749
202306 0.100 305.109 0.109
202309 -0.584 307.789 -0.634
202312 0.220 306.746 0.240
202403 -0.123 312.332 -0.132
202406 -0.082 314.175 -0.087
202409 0.059 315.301 0.062
202412 -1.476 315.605 -1.562
202503 0.502 319.799 0.524
202506 -0.024 322.561 -0.025
202509 0.359 324.800 0.369
202512 0.184 324.054 0.190
202603 -0.632 330.213 -0.639
202606 -0.239 333.952 -0.239

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.86 mean?
Harrow (FRA:3IP) has a Cyclically Adjusted FCF per Share of €-0.86 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Harrow and its competitors.
Is Harrow's Cyclically Adjusted FCF per Share too high?
Harrow's current Cyclically Adjusted FCF per Share is €-0.86. Overall, Harrow has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Harrow's Cyclically Adjusted FCF per Share compare to XERS and PRGO?
Harrow's Cyclically Adjusted FCF per Share of €-0.86 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Harrow and its competitors. Harrow's current Cyclically Adjusted FCF per Share is €-0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harrow stock overvalued right now?
Based on GuruFocus' analysis, Harrow (FRA:3IP) is currently considered Fairly Valued. The stock's GF Value™ is €35.65, compared to a current price of €35.60 — trading 0.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-0.86. Harrow's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Harrow (FRA:3IP), the current Cyclically Adjusted FCF per Share is €-0.86 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harrow (FRA:3IP) Overvalued in 2026?

Based on GuruFocus' analysis, Harrow stock appears to be undervalued. The current stock price of €35.60 is trading 0.1% below its estimated GF Value™ of €35.65. GuruFocus considers Harrow to be Fairly Valued.

Key valuation signals for FRA:3IP:

  • Cyclically Adjusted FCF per Share: €-0.86
  • GF Value™: €35.65 vs. price of €35.60 (0.1% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the FRA:3IP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Harrow Business Description

Other Exchanges HROW:USA
Address 1A Burton Hills Boulevard, Suite 200, Nashville, TN, USA, 37215
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
76GF Score

Get the complete analysis for FRA:3IP

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€35.60
Price
€35.65
GF Value